CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma ; volume:21 ; number:1 ; day:13 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Respiratory research ; 21, Heft 1 (13.10.2020), 1-9, 12.2020
- Urheber
-
Emson, Claire
Diver, Sarah
Chachi, Latifa
Megally, Ayman
Small, Cherrie
Downie, John
Parnes, Jane R.
Bowen, Karin
Colice, Gene
Brightling, Chris E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-020-01513-x
- URN
-
urn:nbn:de:101:1-2020112819103805778758
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Emson, Claire
- Diver, Sarah
- Chachi, Latifa
- Megally, Ayman
- Small, Cherrie
- Downie, John
- Parnes, Jane R.
- Bowen, Karin
- Colice, Gene
- Brightling, Chris E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
The great uncontrolled
The great uncontrolled
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Uncontrolled headache induced by oxcarbazepine
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial